Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Clotrimazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Clotrimazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Candidiasis, Vulvovaginal.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 19, 2025
Lead Product(s) : Clotrimazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Natamycin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Natamycin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Candidiasis, Vulvovaginal.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
May 13, 2024
Lead Product(s) : Natamycin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alcofiltrum
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of the Dietary Food Supplement ALCOFILTRUM in Alleviating Alcohol Hangover Symptoms
Details : Alcofiltrum is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Alcohol Drinking.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 07, 2023
Lead Product(s) : Alcofiltrum
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactofiltrum
Therapeutic Area : Dermatology
Study Phase : Phase II/ Phase III
Sponsor : Moscow State University of Medicine and Dentistry | Moscow Dermatovenerologic Clinical Dispensary
Deal Size : Inapplicable
Deal Type : Inapplicable
A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in Adults
Details : Lactofiltrum is a Probiotic drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Dermatitis, Atopic.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 17, 2010
Lead Product(s) : Lactofiltrum
Therapeutic Area : Dermatology
Highest Development Status : Phase II/ Phase III
Sponsor : Moscow State University of Medicine and Dentistry | Moscow Dermatovenerologic Clinical Dispensary
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lignin Hydrolytic
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : St. Vladimir Moscow Children's Clinical Hospital | Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G.
Deal Size : Inapplicable
Deal Type : Inapplicable
A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis
Details : Lignin Hydrolytic is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Gastroenteritis.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 29, 2010
Lead Product(s) : Lignin Hydrolytic
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : St. Vladimir Moscow Children's Clinical Hospital | Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactofiltrum
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Kirov State Medical Academy | Kirov Regional Clinical Center of Perinatology
Deal Size : Inapplicable
Deal Type : Inapplicable
A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis
Details : Lactofiltrum is a Probiotic drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Vaginosis, Bacterial.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 18, 2010
Lead Product(s) : Lactofiltrum
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Kirov State Medical Academy | Kirov Regional Clinical Center of Perinatology
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
